Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of <scp>MIPSS70</scp>+ v2.0 over <scp>MYSEC‐PM</scp>-Reference-Cited by-同舟云学术

Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC‐PM

Published:2024-01-26 Issue:4 Volume:99 Page:741-744
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Guerra Matteo¹^ORCID,Pasquer Hélène¹²,Daltro de Oliveira Rafael¹,Soret‐Dulphy Juliette¹,Maslah Nabih³⁴,Zhao Lin‐Pierre¹,Marcault Clémence¹,Cazaux Marine¹,Gauthier Nicolas¹,Verger Emmanuelle³⁴,Parquet Nathalie⁵,Vainchenker William⁶,Raffoux Emmanuel⁵,Giraudier Stéphane³⁴^ORCID,Cassinat Bruno³⁴^ORCID,Kiladjian Jean‐Jacques¹⁴^ORCID,Benajiba Lina¹²^ORCID

Affiliation:

1. Université Paris Cité, APHP, Hôpital Saint‐Louis, Centre d'Investigations Cliniques, INSERM CIC 1427 Paris France

2. INSERM UMR 944, Institut de Recherche Saint‐Louis Paris France

3. Laboratoire de Biologie Cellulaire Université Paris Cité, APHP, Hôpital Saint‐Louis Paris France

4. INSERM UMR 1131, Institut de Recherche Saint‐Louis Paris France

5. Département d'hématologie et d'Immunologie Université Paris Cité, APHP, Hôpital Saint‐Louis Paris France

6. Département d'hématologie et d'Immunologie APHP, Hôpital Saint‐Louis Paris France

Funder

Fondation ARC pour la Recherche sur le Cancer

Association Laurette Fugain

Fondation Bettencourt Schueller

Institut National Du Cancer

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27226

Reference6 articles.

1. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

2. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

3. Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis

4. Targeted molecular characterization shows differences between primary and secondary myelofibrosis

5. Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Predictive Models in Myelofibrosis;Current Hematologic Malignancy Reports;2024-08-24

2. Risk models in myelofibrosis—the past, present, and future;American Journal of Hematology;2024-02-23